Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease
Recurrence of Cushing’s disease after successful transsphenoidal surgery occurs in some 30% of the patients and the response to desmopressin shortly after surgery has been proposed as a marker for disease recurrence. The aim of the present study was to evaluate the response to desmopressin over time...
Main Authors: | Alberto Giacinto Ambrogio, Massimiliano Andrioli, Martina De Martin, Francesco Cavagnini, Francesca Pecori Giraldi |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2017-11-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/6/8/791.full |
Similar Items
-
Accuracy of the 10 μg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis
by: Rodrigo Rosa Giampietro, et al.
Published: (2024-01-01) -
Enhancing Cushing’s disease diagnosis: exploring the impact of desmopressin on ACTH gradient during BIPSS
by: Tobias Skrebsky de Almeida, et al.
Published: (2023-08-01) -
Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin
by: Stéphanie Larose, et al.
Published: (2023-06-01) -
Paediatric Cushing’s disease: long-term outcome and predictors of recurrence
by: Martin O. Savage, et al.
Published: (2024-01-01) -
Prognosis criteria for remission of hypercorticism after transsphenoidal endoscopic adenomectomy in patients with Cushing’s disease
by: N. V. Kuritsyna, et al.
Published: (2019-08-01)